4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-030331
Director bought 41,666 shares at $24.00 ($999,984)
- Director acquired 759,606 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M Director | 2020-11-03 | Conversion | +759,606 | 778,353 | D | ||
| BERGER FRANKLIN M Director | 2020-11-03 | Purchase | +41,666 | $24.00 | $999,984 | 820,019 | D |
| Derivatives | |||||||
| BERGER FRANKLIN M Director | 2020-11-03 | Conversion · Series A Convertible Preferred Stock | −400,000 | 0 | D | ||
| BERGER FRANKLIN M Director | 2020-11-03 | Conversion · Series B Convertible Preferred Stock | −132,014 | 0 | D | ||
| BERGER FRANKLIN M Director | 2020-11-03 | Conversion · Series C Convertible Preferred Stock | −131,578 | 0 | D | ||
| BERGER FRANKLIN M Director | 2020-11-03 | Conversion · Series D Convertible Preferred Stock | −60,540 | 0 | D | ||
| BERGER FRANKLIN M Director | 2020-11-03 | Conversion · Series D-1 Convertible Preferred Stock | −35,474 | 0 | D | ||
| Open-market purchases · 41,666 sh · avg $24.00 · $999,984 | |||||||
Loading xslF345X03/doc4.xml…